Iritero 100 mg Injection

Product Description

Iritero 100 mg Injection is a potent topoisomerase inhibitor designed to target advanced colorectal cancer in patients who have not previously undergone chemotherapy for this serious condition. By interfering with the DNA replication process, Iritero effectively hampers cancer cell growth, especially when used in conjunction with 5-fluorouracil and folinic acid, enhancing the overall efficacy of the treatment. This medication is typically administered under strict medical supervision, given its potential side effects, which may include nausea, fatigue, and an increased risk of infection due to its impact on the immune system. Patients should be closely monitored for any adverse reactions, and it is crucial to inform healthcare providers of any pre-existing conditions or medications to avoid dangerous interactions. As with any cancer therapy, the decision to use Iritero should be made collaboratively between the patient and their healthcare team, ensuring a tailored approach to treatment. This injection represents an important option for individuals battling advanced colorectal cancer, aiming to improve their quality of life and overall prognosis. Always consult with a healthcare professional for personalized medical advice and to understand the full spectrum of potential benefits and risks associated with Iritero.